US502504A
(en)
|
|
1893-08-01 |
|
Hermann thoms |
DE487014C
(de)
|
1927-10-23 |
1929-12-09 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von Harnstoffderivaten
|
US1792156A
(en)
*
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
DE511468C
(de)
|
1928-01-18 |
1930-10-30 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
|
DE523437C
(de)
|
1928-12-25 |
1931-05-05 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
US2288422A
(en)
*
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
US2973386A
(en)
*
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
US2502504A
(en)
*
|
1946-10-18 |
1950-04-04 |
John L Botner |
Hogshead
|
DE920245C
(de)
|
1950-04-29 |
1954-11-18 |
Variapat Ag |
Verfahren zur Herstellung von aromatischen, farblosen, wasserloeslichen Trifluormethyl- und Sulfosaeuregruppen enthaltenden unsymmetrischen Harnstoffen bzw. Thioharnstoffen
|
US2683082A
(en)
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
US2722544A
(en)
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
US2781330A
(en)
*
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
NL185660B
(nl)
*
|
1953-03-06 |
|
Great Lakes Chemical Corp |
Werkwijze voor het bereiden van alkali- of aardalkalimetaalbromiden.
|
US2745874A
(en)
*
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
NL193403A
(ko)
*
|
1953-12-22 |
1924-02-17 |
|
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
US2877268A
(en)
*
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
US2960488A
(en)
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
NL254871A
(ko)
|
1959-08-14 |
|
|
|
BE616734A
(ko)
|
1961-04-21 |
|
|
|
CH428747A
(de)
|
1961-09-11 |
1967-01-31 |
Wander Ag Dr A |
Verfahren zur Herstellung neuer Harnstoff- und Thioharnstoffderivate
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
US3284433A
(en)
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
FR90420E
(ko)
|
1965-06-09 |
1968-02-21 |
|
|
US3424760A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424761A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424762A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
SE370866B
(ko)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
DE1768244A1
(de)
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
US3646059A
(en)
*
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
US3668222A
(en)
*
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
US3860645A
(en)
*
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
JPS5031039A
(ko)
|
1973-07-27 |
1975-03-27 |
|
|
US4111680A
(en)
|
1973-07-27 |
1978-09-05 |
Shionogi & Co., Ltd. |
Herbicidal compositions containing 3-isoxazolylurea derivatives
|
US4212981A
(en)
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
US4001256A
(en)
*
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
US4009847A
(en)
*
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
US4111683A
(en)
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
JPS5840946B2
(ja)
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
N−ベンゾイル−n′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
US4071524A
(en)
*
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
US4183854A
(en)
*
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
US4042372A
(en)
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
JPS5562066A
(en)
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
FI800559A
(fi)
|
1979-03-14 |
1980-09-15 |
Hoffmann La Roche |
Urinaemnederivat
|
JPS55124763A
(en)
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
US4468380A
(en)
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
BR8106184A
(pt)
|
1980-01-25 |
1981-11-24 |
Reanal Finomvegyszergyar |
Processo para preparacao de derivados de n-aril-n'-(mono-ou dissubstituido)-ureia
|
ATE9131T1
(de)
|
1980-05-14 |
1984-09-15 |
Ciba-Geigy Ag |
Phenylbenzoylharnstoffe.
|
DE3174885D1
(en)
|
1981-02-03 |
1986-07-31 |
Ici Plc |
Process for the extraction of metal values and novel metal extractants
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4511571A
(en)
*
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
DE3211851A1
(de)
*
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
JPS58203957A
(ja)
*
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
AU1862083A
(en)
|
1982-09-02 |
1984-03-08 |
Duphar International Research B.V. |
Tumor growth inhibitors
|
CA1254212A
(en)
*
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
US4499097A
(en)
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
CH663353A5
(de)
|
1984-03-28 |
1987-12-15 |
Joaquin Amat Larraz |
Mittel gegen krebs.
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
JPS6193163A
(ja)
|
1984-10-12 |
1986-05-12 |
Ishihara Sangyo Kaisha Ltd |
N−ベンゾイル−n′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
DE3541631A1
(de)
*
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
EP0255297B1
(en)
*
|
1986-07-31 |
1993-04-21 |
Beecham Group Plc |
Azabicyclic compounds, process for their preparation, and their pharmaceutical use
|
EP0262560A3
(en)
|
1986-09-29 |
1989-07-05 |
Ishihara Sangyo Kaisha, Ltd. |
Benzoyl urea compound
|
US4835180A
(en)
|
1986-10-02 |
1989-05-30 |
Sterling Drug Inc. |
N-(ω-cyanoalkyl)aminophenols and use as inhibitors of lipoxygenase activity
|
NZ221964A
(en)
*
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
US4983605A
(en)
*
|
1986-10-23 |
1991-01-08 |
Ishihara Sangyo Kaisha Ltd. |
Pharmaceutical composition
|
DE3636190A1
(de)
*
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
DE3853662D1
(de)
|
1987-10-16 |
1995-06-01 |
Ciba Geigy Ag |
Schädlingsbekämpfungsmittel.
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
AU636853B2
(en)
|
1988-08-23 |
1993-05-13 |
Nutrasweet Company, The |
Substituted aryl ureas as high potency sweeteners
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
JPH02196719A
(ja)
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
JP3002204B2
(ja)
*
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
US4973675A
(en)
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
DK40890D0
(da)
|
1990-02-16 |
1990-02-16 |
Ferrosan As |
Substituerede urinstofforbindelser, deres fremstilling og anvendelse
|
NZ238624A
(en)
*
|
1990-06-19 |
1994-08-26 |
Meiji Seika Co |
Pyridine derivatives, compositions, preparations and use thereof
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
CA2078790C
(en)
*
|
1991-01-21 |
1998-10-06 |
Susumu Kamata |
3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
|
US5120842A
(en)
*
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
US5185438A
(en)
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
US5100883A
(en)
*
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
US5118678A
(en)
*
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
FI921595A
(fi)
|
1991-04-17 |
1992-10-18 |
American Home Prod |
Rapamycinkarbamater
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
US5118677A
(en)
*
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
US5185358A
(en)
*
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
AU2552492A
(en)
|
1991-08-23 |
1993-03-16 |
United States of America as represented by The Secretary Department of Health and Human Services, The |
Raf protein kinase therapeutics
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
US5254582A
(en)
|
1992-02-05 |
1993-10-19 |
Eli Lilly And Company |
Antitumor compositions and methods
|
WO1993018028A1
(en)
|
1992-03-12 |
1993-09-16 |
Smithkline Beecham Plc |
Indole derivatives as 5ht1c antagonists
|
WO1993024458A1
(en)
|
1992-05-28 |
1993-12-09 |
Pfizer Inc. |
New n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (acat)
|
US5312820A
(en)
*
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
CN2146707Y
(zh)
|
1992-09-08 |
1993-11-17 |
华东冶金学院 |
高炉软水冷却系统检漏装置
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
TW272942B
(ko)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US6514745B1
(en)
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
US5378725A
(en)
*
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
NZ264063A
(en)
*
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
US5504103A
(en)
*
|
1993-08-25 |
1996-04-02 |
Eli Lilly And Company |
Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
ES2140561T3
(es)
|
1993-09-17 |
2000-03-01 |
Smithkline Beecham Corp |
Proteina de union de farmacos.
|
US6361773B1
(en)
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
CA2133815A1
(en)
*
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
US5596001A
(en)
*
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
JPH09505055A
(ja)
|
1993-11-08 |
1997-05-20 |
スミスクライン・ビーチャム・コーポレイション |
サイトカイン媒介疾患治療用オキサゾール
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
CH686211A5
(de)
*
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US6811779B2
(en)
*
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5447957A
(en)
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
WO1995033458A1
(en)
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
US5480906A
(en)
*
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
US5597719A
(en)
*
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
AU3577995A
(en)
|
1994-10-04 |
1996-04-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives and their use as acat-inhibitors
|
PT708085E
(pt)
|
1994-10-19 |
2002-11-29 |
Novartis Ag |
Eteres antivirais de isosteros de substrato de aspartato protease
|
CA2161376C
(en)
*
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
MA23707A1
(fr)
|
1994-10-28 |
1996-07-01 |
Novozymes As |
Procede pour le finissage chimique de polymeres insolubles
|
TW313568B
(ko)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
FR2729567B1
(fr)
*
|
1995-01-20 |
1997-06-13 |
Oreal |
Composition de teinture d'oxydation des fibres keratiniques et procede de teinture mettant en oeuvre cette composition
|
JPH11503110A
(ja)
*
|
1995-02-17 |
1999-03-23 |
スミスクライン・ビーチャム・コーポレイション |
Il−8受容体拮抗剤
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
DE19512639A1
(de)
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
IL118544A
(en)
|
1995-06-07 |
2001-08-08 |
Smithkline Beecham Corp |
History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
CA2185737A1
(en)
*
|
1995-09-18 |
1997-03-19 |
Akira Yoshida |
Amid and urea derivatives
|
US6075040A
(en)
|
1996-09-05 |
2000-06-13 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
AU7340096A
(en)
|
1995-11-07 |
1997-05-29 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
|
DE69627709T2
(de)
*
|
1995-12-28 |
2004-02-26 |
Kureha Kagaku Kogyo K.K. |
N-(unsubstituierte oder substituierte)-4-substituierte-6-(unsubstituierte oder substituierte)phenoxy-2-pyridincarboxamide oder -thiocarboxamide, verfahren zu deren herstellung sowie herbizide
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6211373B1
(en)
*
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
EP0802187B1
(en)
*
|
1996-04-15 |
2000-02-16 |
Takeda Chemical Industries, Ltd. |
Hydroxypyridine derivatives, their production and their pharmaceutical use
|
AU723730B2
(en)
|
1996-04-23 |
2000-09-07 |
Vertex Pharmaceuticals Incorporated |
Urea derivatives as inhibitors of IMPDH enzyme
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
JPH09301858A
(ja)
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
JP4073489B2
(ja)
|
1996-05-24 |
2008-04-09 |
ニューロサーチ・アクティーゼルスカブ |
酸性基を有するフエニル誘導体、その製造方法及びそれをクロライドチャンネル遮断剤として使用する方法
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
CZ425698A3
(cs)
|
1996-06-27 |
1999-06-16 |
Smithkline Beecham Corporation |
Antagonista IL-8 receptoru
|
IL127666A0
(en)
|
1996-06-27 |
1999-10-28 |
Smithkline Beecham Corp |
IL-8 receptor antagonists
|
EP0932405A4
(en)
*
|
1996-06-27 |
2001-10-17 |
Smithkline Beckman Corp |
IL-8 RECEPTOR ANTAGONISTS
|
EP0907362A4
(en)
|
1996-06-27 |
1999-12-01 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
WO1998017207A1
(en)
|
1996-10-21 |
1998-04-30 |
Synthes Ag Chur |
Surgical prosthetic device
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
WO1998017267A1
(en)
|
1996-10-23 |
1998-04-30 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
EP0963197B1
(en)
|
1996-11-15 |
2010-01-06 |
Cytokine PharmaSciences, Inc. |
Guanylhydrazones useful for treating diseases associated with t cell activation
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
AU4966497A
(en)
|
1996-11-18 |
1998-06-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
|
FR2755967B1
(fr)
*
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
BR9807083A
(pt)
|
1997-01-23 |
2000-04-18 |
Smithkline Beckman Corp |
Antagonistas ao receptor de il-8
|
US5929250A
(en)
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
DE19706061A1
(de)
|
1997-02-07 |
1998-08-13 |
Schering Ag |
Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
|
ES2224365T3
(es)
|
1997-02-12 |
2005-03-01 |
Smithkline Beecham Corporation |
Antagonistas de receptores de il-8.
|
ID22781A
(id)
*
|
1997-04-04 |
1999-12-09 |
Pfizer Prod Inc |
Turunan-turunan nikotinamida
|
DE69830751T2
(de)
|
1997-04-10 |
2006-05-18 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
|
WO1998049150A1
(en)
|
1997-04-25 |
1998-11-05 |
Takeda Chemical Industries, Ltd. |
Triazine derivatives, their production and agrochemical composition
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316479B1
(en)
*
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
RU2249591C2
(ru)
|
1997-05-22 |
2005-04-10 |
Дж.Д. Серл Энд Ко. |
3(5)-гетероарилзамещенные пиразолы в качестве ингибиторов киназы p38
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
US6087381A
(en)
|
1997-05-22 |
2000-07-11 |
G. D. Searle & Company |
Pyrazole derivatives as p38 kinase inhibitors
|
US6344476B1
(en)
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
US6187799B1
(en)
*
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
DE69826695T2
(de)
|
1997-05-23 |
2006-02-02 |
Bayer Pharmaceuticals Corp., West Haven |
Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
|
EP0986382B1
(en)
|
1997-05-23 |
2008-06-25 |
Bayer Pharmaceuticals Corporation |
Raf kinase inhibitors
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
US5985592A
(en)
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
WO1998056377A1
(en)
|
1997-06-13 |
1998-12-17 |
Smithkline Beecham Corporation |
Novel pyrazole and pyrazoline substituted compounds
|
US6093742A
(en)
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
CA2294076A1
(en)
|
1997-06-27 |
1999-01-07 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
6-phenoxypicolinic acid, alkylidenehydrazide derivatives, process for producing the same, and herbicide
|
US6525065B1
(en)
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
AU9802198A
(en)
|
1997-10-21 |
1999-05-10 |
Pharmacia & Upjohn Company |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
PL340261A1
(en)
|
1997-10-31 |
2001-01-29 |
Aventis Pharma Ltd |
Substituted amilides
|
US6080763A
(en)
|
1997-11-03 |
2000-06-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
WO1999028305A1
(en)
|
1997-12-01 |
1999-06-10 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
US6174901B1
(en)
*
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
DE1043995T1
(de)
|
1997-12-22 |
2001-06-07 |
Bayer Corp., Pittsburgh |
INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYLSUBSTITUIERTEN HARNSTOFFEN
|
US7329670B1
(en)
*
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
EP1056725B1
(en)
|
1997-12-22 |
2006-06-07 |
Bayer Pharmaceuticals Corp. |
Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas
|
AU2198999A
(en)
|
1997-12-22 |
1999-07-12 |
Bayer Corporation |
Inhibition of raf kinase using substituted heterocyclic ureas
|
WO1999032111A1
(en)
|
1997-12-22 |
1999-07-01 |
Bayer Corporation |
INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
|
ES2153809T3
(es)
|
1997-12-22 |
2005-07-16 |
Bayer Pharmaceuticals Corporation |
Inhibicion de la cinasa raf por uso de difnil-ureas sustituidas simetrica y asimetricamente.
|
US20120046290A1
(en)
|
1997-12-22 |
2012-02-23 |
Jacques Dumas |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
CA2315715C
(en)
|
1997-12-22 |
2010-06-22 |
Bayer Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
EP1043020A1
(en)
|
1997-12-25 |
2000-10-11 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal composition for percutaneous administration
|
CA2284864A1
(en)
*
|
1998-01-21 |
1999-07-29 |
Zymogenetics, Inc. |
Dialkyl ureas as calcitonin mimetics
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
WO1999042828A2
(en)
|
1998-02-18 |
1999-08-26 |
Theryte Limited |
Treating cancer
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
US6413773B1
(en)
*
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
AU762245B2
(en)
|
1998-09-18 |
2003-06-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
EP1126842A2
(en)
|
1998-11-06 |
2001-08-29 |
Basf Aktiengesellschaft |
Inhibition of the formation of vascular hyperpermeability
|
EP1133552A2
(en)
|
1998-11-25 |
2001-09-19 |
Genetica, Inc. |
Methods and reagents for increasing proliferative capacity and preventing replicative senescence
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
EP1140087A4
(en)
|
1998-12-18 |
2002-04-03 |
Du Pont Pharm Co |
N-UREIDOALKYL-PIPERIDINES FOR USE AS MODULATORS OF THE ACTIVITY OF CHIMIOKIN RECEPTORS
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
JP4632544B2
(ja)
|
1998-12-25 |
2011-02-16 |
あすか製薬株式会社 |
アミノピラゾール誘導体
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
EP1158985B1
(en)
|
1999-01-13 |
2011-12-28 |
Bayer HealthCare LLC |
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
RU2319693C9
(ru)
|
1999-01-13 |
2008-08-20 |
Байер Копэрейшн |
Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
|
EP1140840B1
(en)
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
TWI284642B
(en)
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
US6797823B1
(en)
|
1999-01-22 |
2004-09-28 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives
|
WO2000047577A1
(en)
|
1999-02-12 |
2000-08-17 |
Smithkline Beecham Plc |
Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
|
MXPA01008440A
(es)
|
1999-02-22 |
2002-04-24 |
Boehringer Ingelheim Pharma |
Derivados heterociclicos policiclos como agentes anti-inflamatorios..
|
ATE278674T1
(de)
*
|
1999-03-12 |
2004-10-15 |
Boehringer Ingelheim Pharma |
Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
|
WO2000055152A1
(en)
|
1999-03-12 |
2000-09-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
ES2405316T3
(es)
|
1999-03-19 |
2013-05-30 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la enzima IMPDH
|
DE60044395D1
(de)
|
1999-03-26 |
2010-06-24 |
Euro Celtique Sa |
Arylsubstituierte pyrazole, imidazole, oxazole, thiazole und pyrrole, sowie deren verwendung
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
EP1177186B1
(en)
|
1999-05-05 |
2004-03-31 |
Aventis Pharma Limited |
Ureas and their use as cell adhesion modulators
|
EE200100603A
(et)
|
1999-05-14 |
2003-02-17 |
Imclone Systems Incorporated |
Inimese refraktaarsete kasvajate ravi epidermaalse kasvufaktori retseptori antagonistidega
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
ES2253233T3
(es)
|
1999-07-09 |
2006-06-01 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Procedimiento para sintesis de compuestos de urea heteroaril sustituidos.
|
WO2001004789A1
(fr)
|
1999-07-09 |
2001-01-18 |
Sakai, Yasue |
Dispositif de generation de donnees sur forme d'onde a fonction d'echantillonnage
|
ES2251395T3
(es)
|
1999-07-26 |
2006-05-01 |
Banyu Pharmaceutical Co., Ltd. |
Derivados de biarilureas.
|
AU6339200A
(en)
|
1999-07-28 |
2001-02-19 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
AU1201801A
(en)
|
1999-10-15 |
2001-08-07 |
Van Kampen Group, Inc., The |
Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
|
MXPA02004879A
(es)
|
1999-11-16 |
2002-08-30 |
Boehringer Ingelheim Pharma |
Derivados de urea como agentes antiinflamatorios.
|
US6525046B1
(en)
*
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
PL357099A1
(en)
|
2000-02-07 |
2004-07-12 |
Abbott Gmbh & Co.Kg |
2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
ES2234818T3
(es)
|
2000-03-02 |
2005-07-01 |
Ludwig Institute For Cancer Research |
Procedimiento para tratar canceres que expresan el factor de crecimiento endotelial d.
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
JPWO2001078716A1
(ja)
|
2000-04-19 |
2004-07-22 |
藤沢薬品工業株式会社 |
吸収性が改善された固体分散体
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
WO2002007008A1
(en)
|
2000-04-28 |
2002-01-24 |
Ubink Cornelis Hubertus Johann |
Network procurement system
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
EP1311277A4
(en)
|
2000-07-18 |
2004-08-25 |
Joslin Diabetes Center Inc |
FIBROSIS MODULATION METHOD
|
US6565880B2
(en)
|
2000-07-24 |
2003-05-20 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
CA2417310A1
(en)
|
2000-08-04 |
2002-02-14 |
Wolff M. Kirsch |
Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease
|
WO2002014281A1
(en)
|
2000-08-11 |
2002-02-21 |
Vertex Pharmaceuticals Incorporated |
Pyridine derivatives as inhibitors of p38
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
US6734292B1
(en)
|
2000-08-17 |
2004-05-11 |
The Kitasato Institute |
Pseudoerythromycin derivatives
|
JP2004507526A
(ja)
|
2000-08-31 |
2004-03-11 |
ファイザー・プロダクツ・インク |
ピラゾール誘導体及びそのプロテインキナーゼ阻害剤としての使用
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
DE60134679D1
(de)
|
2000-10-20 |
2008-08-14 |
Eisai R&D Man Co Ltd |
Stickstoff enthaltende aromatische Heterozyklen
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
AU2002223500A1
(en)
|
2000-11-17 |
2002-05-27 |
Novo-Nordisk A/S |
Glucagon antagonists/inverse agonists
|
AU2002217870A1
(en)
|
2000-11-27 |
2002-06-03 |
Eric A. Brill |
System, method, and program for sorting objects
|
EE200300247A
(et)
|
2000-11-28 |
2003-10-15 |
Pfizer Products Inc. |
Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena
|
WO2002044156A2
(en)
|
2000-11-29 |
2002-06-06 |
Glaxo Group Limited |
Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
|
WO2002050091A1
(en)
|
2000-12-21 |
2002-06-27 |
Glaxo Group Limited |
Macrolide antibiotics
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
JP2004532187A
(ja)
|
2001-01-25 |
2004-10-21 |
ギルフォード ファーマシュウティカルズ インコーポレイテッド |
三置換カルボサイクリックサイクロフィリン結合化合物とその用途
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
EP2762140B1
(en)
|
2001-02-19 |
2017-03-22 |
Novartis AG |
Treatment of solid brain tumours with a rapamycin derivative
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
AU2002306618B2
(en)
|
2001-03-07 |
2006-11-09 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
DK1370552T3
(da)
|
2001-03-23 |
2007-05-07 |
Bayer Pharmaceuticals Corp |
Rho-kinase-inhibitorer
|
MXPA03009000A
(es)
|
2001-04-13 |
2004-02-12 |
Boehringer Ingelheim Pharma |
Compuestos benzo-fusionados 1,4-disustituidos.
|
JP2005504727A
(ja)
|
2001-04-13 |
2005-02-17 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症薬として有用なウレア化合物
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
WO2002085857A2
(en)
|
2001-04-20 |
2002-10-31 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
AU2002305260A1
(en)
|
2001-04-27 |
2002-11-11 |
Vertex Pharmaceuticals Incorporated |
Pyrazole derived kinase inhibitors
|
MXPA03010487A
(es)
|
2001-05-16 |
2004-03-09 |
Boehringer Ingelheim Pharma |
Derivados de diarilurea utiles como agentes antiinflamatorios.
|
EP1408950B1
(en)
|
2001-07-11 |
2007-04-25 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Methods of treating cytokine mediated diseases
|
US7371736B2
(en)
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
SE0103838D0
(sv)
|
2001-11-16 |
2001-11-16 |
Astrazeneca Ab |
Pharmaceutical formulation & product
|
EP1769795B1
(en)
|
2001-12-03 |
2013-07-24 |
Bayer HealthCare LLC |
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
|
JP2005526008A
(ja)
|
2001-12-04 |
2005-09-02 |
オニックス ファーマシューティカルズ,インコーポレイティド |
癌を処置するためのraf−mek−erk経路インヒビター
|
ES1050706Y
(es)
|
2001-12-12 |
2002-08-16 |
Climastar Thermostone S L |
Convector electrico mejorado
|
EP1456364B1
(en)
|
2001-12-21 |
2011-03-23 |
The Wellcome Trust |
Mutations in the b-raf gene
|
WO2003060111A2
(en)
|
2001-12-24 |
2003-07-24 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
US20080108672A1
(en)
*
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US20050090474A1
(en)
|
2002-01-16 |
2005-04-28 |
Zvi Naor |
Methods and compositions for enhancing and inhibiting fertilization
|
CA2473910C
(en)
|
2002-01-23 |
2011-03-15 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives as rho-kinase inhibitors
|
MXPA04007191A
(es)
|
2002-01-23 |
2005-03-31 |
Bayer Pharmaceuticals Corp |
Derivados de pirimidina como inhibidores de rho-quinasa.
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
AU2003209118A1
(en)
|
2002-02-11 |
2003-09-04 |
Bayer Pharmaceuticals Corporation |
Aryl ureas as kinase inhibitors
|
US7928277B1
(en)
|
2002-02-11 |
2011-04-19 |
Cox Jr Henry Wilmore |
Method for reducing contamination
|
EP1478358B1
(en)
|
2002-02-11 |
2013-07-03 |
Bayer HealthCare LLC |
Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
US7645878B2
(en)
*
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
AR037647A1
(es)
|
2002-05-29 |
2004-12-01 |
Novartis Ag |
Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina
|
US7476683B2
(en)
|
2002-08-27 |
2009-01-13 |
Merck Patent Gmbh |
Glycinamide derivatives as raf-kinase inhibitors
|
US20060160856A1
(en)
|
2002-09-05 |
2006-07-20 |
Dahl Bjarne H |
Diarylurea derivatives and their use as chloride channel blockers
|
CA2503445C
(en)
|
2002-10-24 |
2012-07-31 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Methylene urea derivatives as raf-kinase inhibitors
|
JP5354836B2
(ja)
|
2002-11-06 |
2013-11-27 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
プロテアソームインヒビターを使用する癌を処置するための方法および組成物
|
CN1714085A
(zh)
|
2002-11-15 |
2005-12-28 |
诺瓦提斯公司 |
药物递送系统
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
GB0317227D0
(en)
|
2003-07-23 |
2003-08-27 |
Pfizer Ltd |
Treatment of male sexual dysfunction
|
ES2357288T3
(es)
*
|
2003-02-28 |
2011-04-25 |
Bayer Healthcare Llc |
Derivados de 2-oxo-1,3,5-perhidrotriazapina útiles en el tratamiento de angiogénesis hiperproliferativa y trastornos inflamatorios.
|
JP4927533B2
(ja)
|
2003-02-28 |
2012-05-09 |
ニッポネックス インコーポレイテッド |
癌その他の疾患の治療に有用な置換ピリジン誘導体
|
UY28213A1
(es)
*
|
2003-02-28 |
2004-09-30 |
Bayer Pharmaceuticals Corp |
Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
|
MXPA05009104A
(es)
|
2003-02-28 |
2006-05-31 |
Bayer Pharmaceuticals Corp |
Derivados de urea biciclica novedosa utiles en el tratamiento del cancer y otros trastornos.
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
PL377124A1
(pl)
|
2003-03-24 |
2006-01-23 |
Merck Patent Gmbh |
Pochodne oksamidu użyteczne jako inhibitory kinazy raf
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
CA2526636C
(en)
*
|
2003-05-20 |
2012-10-02 |
Bayer Pharmaceuticals Corporation |
Diaryl ureas for diseases mediated by pdgfr
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
BRPI0410913A
(pt)
|
2003-06-05 |
2006-06-27 |
Warner Lambert Co |
benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
|
GB2403151A
(en)
|
2003-06-27 |
2004-12-29 |
Intermark Medical Innovations |
A device for rectal lavage
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
CA2531485C
(en)
|
2003-07-07 |
2013-03-26 |
Merck Patent Gmbh |
Malonamide derivatives
|
AU2004255340B2
(en)
|
2003-07-08 |
2008-05-01 |
Novartis Ag |
Use of rapamycin and rapamycin derivatives for the treatment of bone loss
|
JP5001650B2
(ja)
|
2003-07-11 |
2012-08-15 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ベンズイミダゾールカルボキサミド
|
ES2380201T3
(es)
|
2003-07-11 |
2012-05-09 |
Merck Patent Gmbh |
Derivados de benzimidazol
|
WO2005016252A2
(en)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Phosphorus-containing macrocycles
|
WO2005009367A2
(en)
|
2003-07-17 |
2005-02-03 |
Ambit Biosciences Corporation |
Treatment of diseases with kinase inhibitors
|
GB0317229D0
(en)
|
2003-07-23 |
2003-08-27 |
Pfizer Ltd |
Improved process
|
CL2004001834A1
(es)
|
2003-07-23 |
2005-06-03 |
Bayer Pharmaceuticals Corp |
Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
|
AR045134A1
(es)
|
2003-07-29 |
2005-10-19 |
Smithkline Beecham Plc |
Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
JP2007505938A
(ja)
|
2003-09-23 |
2007-03-15 |
ノバルティス アクチエンゲゼルシャフト |
Vegf受容体阻害剤と化学療法剤の組み合わせ
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
CA2542494A1
(en)
*
|
2003-10-15 |
2005-05-06 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene and urea derivatives
|
JP2007509059A
(ja)
|
2003-10-16 |
2007-04-12 |
カイロン コーポレイション |
癌の処置のためのRafキナーゼのインヒビターとしての、2,6−二置換キナゾリン、キノキサリン、キノリンおよびイソキノリン
|
AU2004281151A1
(en)
|
2003-10-16 |
2005-04-28 |
Novartis Vaccines And Diagnostics, Inc. |
Substituted benzazoles and use thereof as inhibitors of Raf kinase
|
DE10349587A1
(de)
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
AU2004291147A1
(en)
|
2003-11-13 |
2005-06-02 |
Ambit Biosciences Corporation |
Urea derivatives as kinase modulators
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
CN1889958A
(zh)
|
2003-12-09 |
2007-01-03 |
美国政府健康及人类服务部 |
抑制免疫应答或治疗增生性疾病的方法
|
EP1692110A1
(en)
|
2003-12-10 |
2006-08-23 |
MERCK PATENT GmbH |
Diacylhydrazine derivatives
|
EP1730111A2
(en)
|
2004-01-30 |
2006-12-13 |
MERCK PATENT GmbH |
Substituted bisarylurea derivatives as kinase inhibitors
|
CN101389345A
(zh)
|
2004-03-19 |
2009-03-18 |
宾州研究基金会 |
治疗黑素瘤的组合方法和组合物
|
MXPA06012394A
(es)
|
2004-04-30 |
2007-01-31 |
Bayer Pharmaceuticals Corp |
Derivados de pirazolilurea sustituidos utiles en el tratamiento de cancer.
|
US20060078617A1
(en)
*
|
2004-08-27 |
2006-04-13 |
Fritz Schueckler |
Pharmaceutical compositions for the treatment of cancer
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
JP5334414B2
(ja)
|
2004-09-06 |
2013-11-06 |
バイエル インテレクチュアル プロパティー ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規のピラゾロピリミジン
|
ES2532377T3
(es)
|
2004-09-29 |
2015-03-26 |
Bayer Healthcare Llc |
Procedimiento de preparación de 4-{4-[({[4-[cloro-3-(trifluorometil)fenil]amino}carbonil) amino]fenoxi}N-metilpiridina-2-carboxamida
|
US8877933B2
(en)
|
2004-09-29 |
2014-11-04 |
Bayer Intellectual Property Gmbh |
Thermodynamically stable form of a tosylate salt
|
US7625931B2
(en)
|
2005-01-14 |
2009-12-01 |
Cgi Pharmaceuticals, Inc. |
Certain substituted diphenyl ureas, as modulators of kinase activity
|
UA93673C2
(ru)
|
2005-03-07 |
2011-03-10 |
Баер Шеринг Фарма Акциенгезельшафт |
Фармацевтическая композиция, которая содержит омега-карбоксиарилзамещенную дифенилмочевину, для лечения paka
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
BRPI0610048A2
(pt)
|
2005-05-27 |
2010-05-25 |
Bayer Healthcare Ag |
terapia de combinação que compreende um composto de diaril uréia e uma pi3, akt quinase ou inibidores de mtor (rapamicinas) para o tratamento de cáncer
|
KR20080012902A
(ko)
|
2005-05-27 |
2008-02-12 |
바이엘 헬스케어 아게 |
질병을 치료하기 위한 디아릴 우레아를 포함하는 병용요법
|
WO2007015947A2
(en)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
CA2622673C
(en)
|
2005-09-21 |
2017-06-27 |
Thomas Maier |
Sulphonylpyrroles and use thereof as inhibitors of hdac s
|
RU2395090C2
(ru)
|
2005-10-21 |
2010-07-20 |
БАЙЕР ХелсКер ЛЛСи |
Способы прогнозирования и предсказания рака и мониторинг терапии раковых заболеваний
|
EP1968589A2
(en)
*
|
2005-10-31 |
2008-09-17 |
Bayer Pharmaceuticals Corporation |
Combinations comprising sorafenib and interferon for the treatment of cancer
|
US8329408B2
(en)
*
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
WO2007053573A2
(en)
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Treatment of cancer with sorafenib
|
WO2007056011A2
(en)
|
2005-11-02 |
2007-05-18 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
MY144860A
(en)
|
2005-11-10 |
2011-11-30 |
Bayer Schering Pharma Ag |
Diaryl ureas for treating pulmonary hypertension
|
US20100035888A1
(en)
|
2005-11-10 |
2010-02-11 |
Bater Healthcare AG |
Diaryl Urea for Treating Pulmonary Hypertension
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
EP1963849A2
(en)
|
2005-11-14 |
2008-09-03 |
Bayer Healthcare, LLC |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
EP1957069A2
(en)
|
2005-11-14 |
2008-08-20 |
Bayer Healthcare, LLC |
Treatment of cancers with acquired resistance to kit inhibitors
|
WO2007064872A2
(en)
|
2005-12-01 |
2007-06-07 |
Bayer Healthcare Llc |
Urea compounds useful in the treatment of cancer
|
CA2633417A1
(en)
|
2005-12-15 |
2007-06-21 |
Bayer Healthcare Ag |
Diaryl ureas for treating virus infections
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
EP1962841A1
(en)
|
2005-12-15 |
2008-09-03 |
Bayer HealthCare AG |
Diaryl urea for treating virus infections
|
US8580798B2
(en)
|
2005-12-21 |
2013-11-12 |
Bayer Intellectual Property Gmbh |
Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
|
WO2007087575A2
(en)
|
2006-01-24 |
2007-08-02 |
University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
CA2648106A1
(en)
|
2006-03-31 |
2007-11-01 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
EP2094268A2
(en)
*
|
2006-05-26 |
2009-09-02 |
Bayer HealthCare, LLC |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
AR062927A1
(es)
|
2006-10-11 |
2008-12-17 |
Bayer Healthcare Ag |
4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
|
JP2010509253A
(ja)
*
|
2006-11-09 |
2010-03-25 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
4−[4−({[4−クロロ−3−(トリフルオロメチル)フェニル]カルバモイル}アミノ)−3−フルオロフェノキシ]−n−メチルピリジン−2−カルボキサミドの多形iii
|
EP2089003A1
(en)
|
2006-11-09 |
2009-08-19 |
Abbott GmbH & Co. KG |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
CA2669158A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
|
DE602007012589D1
(de)
|
2006-12-20 |
2011-03-31 |
Bayer Healthcare Llc |
4-ä4-Ä(ä3-TERT-BUTYL-1-Ä3-(HYDROXYMETHYL)-PHENYLÜ-1H-PYRAZOL-5-YLü-CARBAMOYL)-AMINOÜ-3-FLUOROPHENOXYü -N-METHYLPYRIDIN-2-CARBOXAMID SOWIE PRODRUGS UND
|
WO2008079972A2
(en)
|
2006-12-20 |
2008-07-03 |
Bayer Healthcare Llc |
4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
|
JP5885012B2
(ja)
|
2007-01-19 |
2016-03-15 |
バイエル・ヘルスケア・エルエルシーBayer HealthCareLLC |
Kit阻害剤に対して獲得した抵抗性を有する癌の処置
|
EP2114403A2
(en)
|
2007-01-19 |
2009-11-11 |
Bayer Healthcare, LLC |
Treatment of cancers having resistance to chemotherapeutic agents
|
WO2008156024A1
(ja)
|
2007-06-21 |
2008-12-24 |
Sharp Kabushiki Kaisha |
光検出装置、及びそれを備えた表示装置
|
JP5076072B2
(ja)
|
2008-03-24 |
2012-11-21 |
矢崎総業株式会社 |
圧着端子、及びこの圧着端子を用いた圧着構造
|
WO2009156070A1
(en)
|
2008-06-25 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Diaryl urea for treating heart failure
|
CA2741087A1
(en)
|
2008-10-21 |
2010-04-29 |
Bayer Healthcare Llc |
Identification of signature genes associated with hepatocellular carcinoma
|
JP5077375B2
(ja)
|
2010-02-26 |
2012-11-21 |
井関農機株式会社 |
コンバイン
|